Ravi Rao is the founder of Sitryx Therapeutics. Sitryx Therapeutics has raised $30M in total funding. Latest round: Series A. Based in Oxford, UK.
Ravi M. Rao was appointed as Chief Medical Officer at Sitryx Therapeutics in April 2022. He is a rheumatologist and pharmaceutical physician with over fifteen years of leadership experience in pharmaceutical and biotechnology companies. Prior to Sitryx, he held roles at Swedish Orphan Biovitrum and Aeglea Biotherapeutics.
Full founder directory · Investor directory · Company funding database · Fundraising library